Bank of America’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,720
| Closed | -$148 | – | 7281 |
|
|
2023
Q3 | $148 | Hold |
1,720
| – | – | ﹤0.01% | 6506 |
|
|
2023
Q2 | $963 | Hold |
1,720
| – | – | ﹤0.01% | 6360 |
|
|
2023
Q1 | $1.96K | Hold |
1,720
| – | – | ﹤0.01% | 6393 |
|
|
2022
Q4 | $1.93K | Hold |
1,720
| – | – | ﹤0.01% | 6429 |
|
|
2022
Q3 | $4K | Buy |
1,720
+1,719
| +171,900% | +$4K | ﹤0.01% | 6590 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7572 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 7873 |
|
|
2021
Q4 | $0 | Sell |
1
-6,213
| -100% | – | ﹤0.01% | 7759 |
|
|
2021
Q3 | $18K | Buy |
6,214
+3,463
| +126% | +$10K | ﹤0.01% | 6522 |
|
|
2021
Q2 | $8K | Sell |
2,751
-59,258
| -96% | -$172K | ﹤0.01% | 6534 |
|
|
2021
Q1 | $202K | Buy |
62,009
+56,104
| +950% | +$183K | ﹤0.01% | 5382 |
|
|
2020
Q4 | $24K | Sell |
5,905
-52,885
| -90% | -$215K | ﹤0.01% | 5781 |
|
|
2020
Q3 | $318K | Buy |
58,790
+47,095
| +403% | +$255K | ﹤0.01% | 4437 |
|
|
2020
Q2 | $79K | Buy |
11,695
+8,707
| +291% | +$58.8K | ﹤0.01% | 5218 |
|
|
2020
Q1 | $9K | Sell |
2,988
-9,301
| -76% | -$28K | ﹤0.01% | 5778 |
|
|
2019
Q4 | $86K | Buy |
12,289
+7,713
| +169% | +$54K | ﹤0.01% | 5239 |
|
|
2019
Q3 | $17K | Sell |
4,576
-3,647
| -44% | -$13.5K | ﹤0.01% | 5781 |
|
|
2019
Q2 | $31K | Buy |
8,223
+6,275
| +322% | +$23.7K | ﹤0.01% | 5686 |
|
|
2019
Q1 | $7K | Sell |
1,948
-2,184
| -53% | -$7.85K | ﹤0.01% | 5972 |
|
|
2018
Q4 | $31K | Buy |
+4,132
| New | +$31K | ﹤0.01% | 5607 |
|